Vyloy

Astellas

Pharma

Astellas shifts investment focus to later-stage programs: exec

As part of a reprioritization, Astellas is shifting its focus more to later-stage opportunities, chief strategy officer Adam Pearson said.

Angus Liu Feb 12, 2025 1:30pm

Astellas

Astellas wins class-first gastric cancer nod for Vyloy

Oct 18, 2024 3:39pm